Our observations also agree with previous investigations and meta‐analyses, which found that CSF tau levels (including t‐tau and p‐tau) in CAA fall between the levels in AD and healthy controls [3, 32, 33, 34]. The gene discussed is MAPT; the disease is Alzheimer disease.